Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Devlin
    Devlin
  3. Wolden
    Wolden
  4. Wu
    Wu
  5. Lee
    Lee
  6. Zhang
    Zhang
  7. Perales
    Perales
  8. Kernan
    Kernan
  9. Riely
    Riely
  10. Yamada
    Yamada

Groups

  1. Department of Medicine (193)
  2. Survivorship Research (125)
  3. Surgery (121)
  4. Radiation Oncology, Department of (119)
  5. Center for Hematologic Malignancies (99)
  6. Solid Tumor Oncology Division (99)
  7. GSK Faculty (92)
  8. Hematologic Malignancies, Division of (80)
  9. Epidemiology and Biostatistics (64)
  10. Biostatistics Service (54)
Search Within
  1. "2014"
Formats
  1. Journal Article (271)
  2. Meeting Abstract (200)
  3. Book Section (19)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (193)
  2. Survivorship Research (125)
  3. Surgery (121)
  4. Radiation Oncology, Department of (119)
  5. Center for Hematologic Malignancies (99)
  6. Solid Tumor Oncology Division (99)

More Groups

People
  1. Sergio Giralt (34)
  2. Andreas Rimner (25)
  3. Sean Devlin (21)
  4. Suzanne Wolden (21)
  5. Abraham Wu (20)
  6. Juliet Barker (19)

More People

Years
  1. 2014 (491)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (131)
  2. Biology of Blood and Marrow Transplantation (60)
  3. European Journal of Cancer (37)
  4. Journal of Thoracic Oncology (31)
  5. Gynecologic Oncology (25)
  6. Journal of Sexual Medicine (15)

More Publications

Results (491)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibition of the cell cycle regulated Cdc7 kinase pathway is an efficacious therapeutic approach for hematologic malignancies and solid tumors
    Meeting Abstract

    Santos, R.; Shum, D.; Carrillo, D.; Zhang, R.; Churchill, M.; Mukherjee, S.; Brentjens, R.; Radu, C.; Kelly, T. J.; Djaballah, H.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Druggability of p16 deleted pediatric leukemia: The novel cell line POETIC3 identifies potential agents and drug combinations for mechanism based targeted therapeutics
    Meeting Abstract

    Reimer, J.; Kovulchuk, A.; Ruan, Y.; Shah, R.; Jayanthan, A.; Perinpanayagam, M.; Truong, T.; Auer-Grzesiak, I.; Luider, J.; Kovulchuk, O.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Clinical safety and activity in a phase I trial of AG-120, a first in class, selective, potent inhibitor of the IDH1-mutant protein, in patients with IDH1 mutant positive advanced hematologic malignancies
    Meeting Abstract

    Pollyea, D. A.; de Botton, S.; Fathi, A. T.; Stein, E. M.; Tallman, M. S.; Agresta, S.; Bowden, C.; Fan, B.; Prah, M.; Yang, H.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Prevalence and clinical implications of Epstein-Barr virus infection in de novo diffuse large B-cell lymphoma in western countries: A report from The International DLBCL Rituximab-CHOP Consortium Program
    Meeting Abstract

    Ok, C. Y.; Xu-Monette, Z. Y.; Visco, C.; Tzankov, A.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y. L.; Bhagat, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Novel anti-tumor activity of targeted LSD1 inhibition by GSK2879552
    Meeting Abstract

    Mohammad, H.; Smitheman, K.; Van Aller, G.; Cusan, M.; Kamat, S.; Liu, Y.; Johnson, N.; Hann, C.; Armstrong, S.; Kruger, R.
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Safety and durability of ponatinib in patients with Philadelphia chromosome-positive (Ph+) leukemia: Long-term follow-up of an ongoing phase 1 study
    Meeting Abstract

    Mauro, M. J.; Cortes, J. E.; Kantarjian, H. M.; Shah, N. P.; Bixby, D.; Flinn, I. W.; O'Hare, T.; Hu, S. M.; Rivera, V. M.; Clackson, T.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • SF3B1 mutations are associated with alternative splicing in ER-positive breast cancer
    Meeting Abstract

    Maguire, S.; Leonidou, A.; Wai, P.; Marchio, C.; Ng, C. K. Y.; Weigelt, B.; Sapino, A.; Vincent-Salomon, A.; Reis-Filho, J. S.; Natrajan, R.
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Pegfilgrastim for patients with newly diagnosed diffuse large B-cell lymphoma undergoing dose adjusted EPOCH-R: The MSKCC experience
    Meeting Abstract

    Lunning, M. A.; Maragulia, J.; Horwitz, S. M.; Moskowitz, C. H.; Noy, A.; Zelenetz, A. D.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Modified SMILE (mSMILE) is active in the treatment of extranodal natural killer/T-cell lymphoma: A single center US experience
    Meeting Abstract

    Lunning, M.; Pamer, E.; Maragulia, J.; Straus, D.; Yahalom, J.; Moskowitz, A.; Zelenetz, A. D.; Horwitz, S.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Tyk2-src dependence of kidney cancer
    Meeting Abstract

    Krishnan, B.; Hanna, S. C.; Wilson, H. L.; Bailey, S. T.; Damrauer, J. S.; Simamura, T.; Levine, R. L.; Wong, K. K.; Johnson, G. L.; Kim, W. Y.
    European Journal of Cancer (2014)

    Fulltext@MSK | Save